Nigeria’s top pharmaceutical companies have recorded their strongest profits in at least five years, driven by the exodus of multinationals, which has created room for local manufacturers to fill the widening supply gap in Africa’s biggest consumer market.
Fidson, MeCure, and May & Baker,
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
